POLE and endometrial endometrioid carcinoma: The ultramutated subgroup mostly consists of high-grade endometrioid endometrial carcinomas, presenting a very high mutational frequency, with mutations in the Polymerase-ε (POLE) exonuclease domain, and a good prognosis.